drugset / Trial / NCT03484650
Systemic Lidocaine Infusion for Pain Control in Ventral Hernia
RandomizedParallel-groupTriple-blindPrevention
Summary
Ventral hernia repair leads to more than expected pain. This is thought to be secondary to nerve pain at the lateral transfixion sutures. Systemic lidocaine given pre-op has in other situations decreased neurogenic pain. This study will examine its effects on pain experienced after ventral hernia repair.
Timeline
- Start
- 2020-01-14
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
Outcome
Outcome not reported
Stopped: “Lack of available resources to complete study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 0.5 mg/kg | Intravenous |
Indications
No indication recorded.